Consistent with this result, analysis of Cancer Dependency Map data (Broad Institute) identifies that Ewing sarcoma cell lines are significantly more sensitive to CRISPR-mediate knockout of thioredoxin reductase than other cancer cell lines (Figure 2A) (37, 38). The gene discussed is PRDX5; the disease is Ewing sarcoma.